• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[内源性库欣综合征和肢端肥大症患者的血清肌动蛋白水平:横断面病例对照研究]

[Serum Myokines Levels in Patients with Endogenous Cushing Syndrome and Acromegaly: Cross-Sectional Case−Control Study].

作者信息

Kolesnikova L I, Madaeva I M, Semenova N V, Osipova E V, Darenskaya M A

出版信息

Vestn Ross Akad Med Nauk. 2016;71(3):240-7. doi: 10.15690/vramn659.

DOI:10.15690/vramn659
PMID:29297640
Abstract

BACKGROUND

Myokines are produced and released by muscle cells in response to muscular contractions. Endogenous Cushing syndrome (CS) and acromegaly cause significant changes in muscle tissue leading to atrophy or hypertrophy. However, there is no data whether these endocrine abnormalities influence myokine secretion.

AIMS

To evaluate serum levels of myostatin, interleukin-6 (IL6) and irisin in patients with CS and acromegaly.

MATERIALS AND METHODS

Fasting serum samples were taken and stored in aliquot at ≤-20°C from consecutive subjects with clinically evident and biochemically confirmed active CS, acromegaly and healthy volunteers matched by age, sex and body mass index (BMI). Commercially available kits were used to assay serum myokine levels. Grip strength was measured by a dynamometer. Insulin-like growth factor-1 (IGF1) was measured by immunochemiluminescence assay (Liaison), twenty-four hours urine free cortisol (24hUFC) ― by immunochemiluminescence assay (Vitros ECi), salivary free cortisol ― by electrochemiluminescence assay (Cobas). One-way ANOVA was utilized to assess the difference between groups.

RESULTS

We enrolled 88 subjects: 30 patients suffered from CS (group 1), 28 ― acromegaly (2) and 30 matched healthy controls (3) with no difference among the groups in sex, age and BMI (p=0.492, 0.062 and 0.174 respectively). Mean 24hUFC in subjects with CS and mean IGF1 in subjects with acromegaly were significantly higher as compared to other groups (p<0.001). Right-hand grip strength was lower in patients with CS as compared to both patients with acromegaly and healthy subjects (p=0.04). However, among these young adults we did not find statistically significant differences in measured myokines levels: irisin ― p=0.15; IL6 ― p=0.34; myostatin ― p=0.50. There was a significant correlation between myostatin and irisin in the whole group of people and in every separately analyzed subset of patients (p<0.001), but no correlation was found between any measured myokines and 24hUFC or IGF1.

CONCLUSIONS

Hypercortisolism or supraphysiological IGF1 levels do not significantly influence serum levels of myostatin, IL6 and irisin in young adults.

摘要

背景

肌动蛋白是肌肉细胞在肌肉收缩时产生并释放的。内源性库欣综合征(CS)和肢端肥大症会导致肌肉组织发生显著变化,进而导致萎缩或肥大。然而,尚无数据表明这些内分泌异常是否会影响肌动蛋白的分泌。

目的

评估CS和肢端肥大症患者血清中肌肉生长抑制素、白细胞介素-6(IL6)和鸢尾素的水平。

材料与方法

采集连续的临床症状明显且经生化确诊的活动性CS患者、肢端肥大症患者以及年龄、性别和体重指数(BMI)相匹配的健康志愿者的空腹血清样本,并在≤-20°C下分装保存。使用市售试剂盒检测血清肌动蛋白水平。用测力计测量握力。通过免疫化学发光法(Liaison)检测胰岛素样生长因子-1(IGF1),通过免疫化学发光法(Vitros ECi)检测24小时尿游离皮质醇(24hUFC),通过电化学发光法(Cobas)检测唾液游离皮质醇。采用单因素方差分析评估组间差异。

结果

我们纳入了88名受试者:30例CS患者(第1组),28例肢端肥大症患者(第2组)和30名匹配的健康对照者(第3组),三组在性别、年龄和BMI方面无差异(分别为p = 0.492、0.062和0.174)。与其他组相比,CS患者的平均24hUFC和肢端肥大症患者的平均IGF1显著更高(p < 0.001)。与肢端肥大症患者和健康受试者相比,CS患者的右手握力较低(p = 0.04)。然而,在这些年轻人中,我们未发现所测肌动蛋白水平存在统计学显著差异:鸢尾素——p = 0.15;IL6——p = 0.34;肌肉生长抑制素——p = 0.50。在整组人群以及每个单独分析的患者亚组中,肌肉生长抑制素与鸢尾素之间存在显著相关性(p < 0.001),但在所测的任何肌动蛋白与24hUFC或IGF1之间未发现相关性。

结论

高皮质醇血症或超生理水平的IGF1对年轻人血清中肌肉生长抑制素、IL6和鸢尾素的水平无显著影响。

相似文献

1
[Serum Myokines Levels in Patients with Endogenous Cushing Syndrome and Acromegaly: Cross-Sectional Case−Control Study].[内源性库欣综合征和肢端肥大症患者的血清肌动蛋白水平:横断面病例对照研究]
Vestn Ross Akad Med Nauk. 2016;71(3):240-7. doi: 10.15690/vramn659.
2
Myokines in Acromegaly: An Altered Irisin Profile.肢端肥大症中的肌肉因子:鸢尾素谱的改变。
Front Endocrinol (Lausanne). 2021 Nov 2;12:728734. doi: 10.3389/fendo.2021.728734. eCollection 2021.
3
Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?2型糖尿病中肌肉生长抑制素与鸢尾素的关系:一种针对不良代谢状态的代偿机制?
Endocrine. 2016 Apr;52(1):54-62. doi: 10.1007/s12020-015-0758-8. Epub 2015 Oct 5.
4
Irisin and Myostatin Levels in Patients with Graves' Disease.格雷夫斯病患者的鸢尾素和肌肉生长抑制素水平
Arch Med Res. 2016 Aug;47(6):471-475. doi: 10.1016/j.arcmed.2016.11.002.
5
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing.高海拔登山2周后的血清鸢尾素和肌肉生长抑制素水平。
PLoS One. 2017 Jul 21;12(7):e0181259. doi: 10.1371/journal.pone.0181259. eCollection 2017.
6
Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.鸢尾素 mRNA 及其在健康和病态肥胖人群中的循环水平与其他肌因子的关系。
Eur J Endocrinol. 2013 Oct 21;169(6):829-34. doi: 10.1530/EJE-13-0276. Print 2013 Dec.
7
Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly.在肢端肥大症患者中,循环中鸢尾素水平的升高与心血管危险因素有关。
Hormones (Athens). 2019 Dec;18(4):435-442. doi: 10.1007/s42000-019-00151-3. Epub 2019 Nov 6.
8
Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies.通过 DXA 和握力计评估的肌肉减少症:炎症性肌病中损伤、残疾和肌因子失衡的潜在标志物。
Rheumatology (Oxford). 2024 Sep 1;63(9):2503-2514. doi: 10.1093/rheumatology/keae207.
9
Myokines in treatment-naïve patients with cancer-associated cachexia.癌症相关性恶病质治疗初治患者中的肌肉因子。
Clin Nutr. 2021 Apr;40(4):2443-2455. doi: 10.1016/j.clnu.2020.10.050. Epub 2020 Nov 2.
10
Roles of natural products on myokine expression and secretion in skeletal muscle atrophy.天然产物对骨骼肌萎缩中肌因子表达和分泌的作用。
Gen Comp Endocrinol. 2024 Sep 1;355:114550. doi: 10.1016/j.ygcen.2024.114550. Epub 2024 May 18.

引用本文的文献

1
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status.评估糖皮质激素状态的当前挑战和未来方向。
Endocr Rev. 2024 Nov 22;45(6):795-817. doi: 10.1210/endrev/bnae016.